The MedTech Europe blog

Archives for

In June, the US Supreme Court issued its opinion in the Myriad case (Association for Molecular Pathology v. Myriad Genetics Inc.).  The Supreme Court had been asked a seemingly simple question: “Are human genes patentable?”, and concluded that naturally occurring gene sequences are no longer patentable in the US.  In Europe, isolated gene sequences are… » read more

Posted by MedTech Europe

A surprising few things have happened lately. Firstly, the weather in Belgium CAN be nice and pleasing to a Franco-Italian such as myself. Secondly, the ENVI Committee vote that was scheduled to take place on 10 July was postponed to 18 September for both the Medical Devices and In Vitro Diagnostics Directives. If I did… » read more

Posted by MedTech Europe

It has been my privilege to serve as Executive Producer of Lab Tests Online for the last twelve years, overseeing its launch in the United States and expansion into 16 other countries. Of course, to say I “oversaw” the launch does not quite capture the roll-up-the-sleeves intensity of those early days in 2001 when I… » read more

Posted by MedTech Europe

In the past few weeks, the Swiss newspapers have been littered with an uncomfortable and poisonous prospect: the U.S. A financial force banging its chest from its modest economic recovery is demanding tax justice from Switzerland. The stable currency, neutrality and talented investment acumen that the Swiss have quietly touted to global investors has allowed… » read more

Posted by MedTech Europe

In the past few weeks, the Swiss newspapers have been littered with an uncomfortable and poisonous prospect: the U.S. A financial force banging its chest from its modest economic recovery is demanding tax justice from Switzerland. The stable currency, neutrality and talented investment acumen that the Swiss have quietly touted to global investors has allowed… » read more

Posted by MedTech Europe